Altheus Therapeutics announces completion of Zoenasa phase I actually trial for ulcerative colitis Altheus Therapeutics, Inc. Related StoriesAlport syndrome: an interview with Dr Paul Grint, CMO, RegulusLenvatinib trial offers hope for thyroid cancer patientsExpanded use for IntelliCap with additional CE Mark for aspiration of fluidsNearly 1.2 million Americans have problems with inflammatory bowel disease. Both most common forms, ulcerative colitis and Crohn’s disease, are chronic lifelong conditions which impact the quality of life significantly.Prof Pirker is normally co-chair of the scientific committee of a new medical meeting, the European Multidisciplinary Meeting in Thoracic Oncology , being held for the first time this full year, 1-3 May, in Lugano, Switzerland. The conference aims to further clinical and scientific cooperation between disciplines to greatly help in the fight against lung cancer. In the last 5 years, researchers established that for patients with operable cancer, medical procedures followed by chemotherapy can result in good outcomes. Now, large clinical trials are starting to evaluate that adding molecular targeted therapies can further enhance the chance of an effective outcome for some patients. In addition, doctors are now wanting to refine their remedies predicated on the clinical characteristics of individual patients, and predicated on the molecular profile of their tumour.

Other articles from category "gynecology":

Random articles